Oncology One is committed to being at the forefront of industry conversations and scientific progress in the cancer space.
That’s why our team is attending the 34th Lorne Cancer Conference this week. This is Australia’s preeminent multidisciplinary cancer research event, uniting internationally regarded speakers to examine tumour immunology, genomics, molecular signalling, lung and pancreatic cancers, and more.
Oncology One CEO, Dr Joanne Boag, will be in attendance:
“We are thrilled to be sponsoring the conference’s first Oral Presentation Award. An extension of our work to build a connected industry and to work alongside credible research partners to develop and execute high potential drug discovery projects,” she said.